scholarly journals Exploration of High-Grade Transformation and Postoperative Radiotherapy on Prognostic Analysis for Primary Adenoid Cystic Carcinoma of the Head and Neck

2021 ◽  
Vol 11 ◽  
Author(s):  
Yuelu Zhu ◽  
Xinyi Zhu ◽  
Xuemin Xue ◽  
Ye Zhang ◽  
Chunfang Hu ◽  
...  

BackgroundDespite Adenoid cystic carcinoma (ACC) with cribriform or tubular components being recognized as a potentially indolent malignancy, ACC displaying solid or, more rarely, high-grade transformation (HGT) components is considered a more aggressive variant of the disease. As it is difficult to measure the proportion of the solid component objectively, and the role of HGT in the current grading system remains unclear, the prognostic influence of tumor grading remains controversial. In addition, postoperative radiotherapy (PORT) has been proven to be effective in local control of ACC of the head and neck (ACCHN) with a high rate of nerve invasion and close surgical margin. However it remains to be explored that whether PORT could improve the survival of patients with ACC, particularly those with HGT.MethodsA series of 73 surgically treated primary ACCHN cases were retrospectively accessed. Immunohistochemical staining was performed to observe the biphasic ductal-myoepithelial differentiation and to identify the HGT components of ACC for tumor grading. The correlation between tumor grading and clinicopathological characteristics was analyzed. Univariate and multivariate prognostic analysis were performed for progression-free survival (PFS) and overall survival (OS).ResultsOf the 73 included cases, 47 were grade I-II ACC and 26 were grade III ACC. Among the grade III cases, 14 with loss of biphasic ductal-myoepithelial differentiation identified by immunostaining were classified as HGT, and could be distinguished from conventional grade III cases. These HGT cases were correlated with a high propensity of lymph node metastases and more advanced stage. Univariate analysis demonstrated that tumor grading, perineural invasion, T stage, stage groups, and PORT were predictors for PFS, whereas tumor grading, margin status, and PORT were predictors for OS. However, only tumor grading and PORT were independent predictors for PFS and OS. The patients with HGT had significantly worse prognosis than those with conventional ACC. Moreover, disease progression tended to occur more frequently in younger patients. Among the patients with HGT, those who received PORT had a longer median survival time than those who did not.ConclusionHGT ACC identified by loss of biphasic differentiation should be considered in tumor grading. Tumor grading and PORT were independent predictors for disease progression and OS in surgically treated ACCHN patients.

2019 ◽  
Vol 46 (6) ◽  
pp. 934-939 ◽  
Author(s):  
Masaru Miyazaki ◽  
Mikiko Aoki ◽  
Kaori Koga ◽  
Makoto Hamasaki ◽  
Yoshikazu Sugiyama ◽  
...  

2012 ◽  
Vol 7 (1) ◽  
pp. 85-92 ◽  
Author(s):  
Prokopios P. Argyris ◽  
Stefan E. Pambuccian ◽  
Zuzan Cayci ◽  
Charanjeet Singh ◽  
Konstantinos I. Tosios ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Shengjin Dou ◽  
Rongrong Li ◽  
Ning He ◽  
Menghuan Zhang ◽  
Wen Jiang ◽  
...  

Novel systemic agents and effective treatment strategies for recurrence adenoid cystic carcinoma (ACC) of the head and neck are still worthy of further exploration. Here, we analyzed the mutations and expression profiles of 75 Chinese ACC patients, characterized the prognostic value of the immune signature for recurrence or distant metastasis, and explored the potential of immunotherapeutic biomarkers in ACC. In general, MYB fusion and somatic mutations accounted for a high proportion, which was 46.7% (35/75). ACCs displayed an overall low mutation burden and lack of programmed cell death ligand-1 (PD-L1) expression. The antigen-presenting machinery (APM) expression score and immune infiltration score (IIS) were the lowest among ACC patients, compared with other cancer types. For 61 primary cases, the locoregional recurrence-free survival (LRRFS) was statistically significantly correlated with the IIS [univariate analysis; hazard ratio (HR) = 0.32; 95% CI, 0.11–0.92; p = 0.035] and T-cell infiltration score (TIS) (univariate analysis; HR = 0.33; 95% CI, 0.12–0.94; p = 0.037]. Patients with lower IIS (log-rank p = 0.0079) or TIS (log-rank p = 0.0079) had shorter LRRFS. Additionally, solid pattern was also a prognostic factor related to locoregional recurrence, whereas postoperative radiotherapy (PORT) exerted its beneficial effects. We further evaluated the pretreatment immune profile of five ACC patients treated with PD-1 inhibitors. Patients who responded to camrelizumab or pembrolizumab observed elevated APM and TIS, compared with patients with progressive disease. Our study highlights the immune infiltration pattern and messenger RNA (mRNA) signatures of Chinese ACC patients, which has the potential value for prognosis and immunotherapy.


2011 ◽  
Vol 25 (4) ◽  
pp. 529-536 ◽  
Author(s):  
Jennifer M Boland ◽  
Ellen D McPhail ◽  
Joaquín J García ◽  
Jean E Lewis ◽  
David J Schembri-Wismayer

2013 ◽  
Vol 30 (3) ◽  
pp. 333-336 ◽  
Author(s):  
Hamide Sayar ◽  
Sulen Sarioglu ◽  
Sevgi Bakaris ◽  
Ilhami Yildirim ◽  
Huseyin Oztarakci

Sign in / Sign up

Export Citation Format

Share Document